These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 32551796)

  • 1. Usefulness of Ninjin'yoeito for Chronic Obstructive Pulmonary Disease Patients with Frailty.
    Hirai K; Homma T; Matsunaga T; Akimoto K; Yamamoto S; Suganuma H; Kashima A; Sato H; Ebato T; Miyata Y; Ohta S; Inoue H; Kusumoto S; Suzuki S; Tanaka A; Sagara H
    J Altern Complement Med; 2020 Aug; 26(8):750-757. PubMed ID: 32551796
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of Ninjin'yoeito on Patients with Chronic Obstructive Pulmonary Disease and Comorbid Frailty and Sarcopenia: A Preliminary Open-Label Randomized Controlled Trial.
    Ohbayashi H; Ariga M; Ohta K; Kudo S; Furuta O; Yamamoto A
    Int J Chron Obstruct Pulmon Dis; 2024; 19():995-1010. PubMed ID: 38737191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A retrospective study on the efficacy of Ninjin'yoeito on fatigue in patients with interstitial pneumonia.
    Kushima H; Kinoshita Y; Fujita M; Ishii H
    Neuropeptides; 2021 Oct; 89():102178. PubMed ID: 34298370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement in Frailty in a Patient With Severe Chronic Obstructive Pulmonary Disease After Ninjin'yoeito Therapy: A Case Report.
    Kuniaki H; Akihiko T; Tetsuya H; Hatsuko M; Tomoko K; Shin O; Sojiro K; Mayumi Y; Fumihiro Y; Shintaro S; Tsukasa O; Hironori S
    Front Nutr; 2018; 5():71. PubMed ID: 30234120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of Ninjin'yoeito along with iron supplementation therapy for preoperative anemia, fatigue, and anxiety in patients with gynecological disease: an open-label, single-center, randomized phase-II trial.
    Yagi T; Sawada K; Miyamoto M; Kinose Y; Nakagawa S; Takiuchi T; Kodama M; Kobayashi E; Hashimoto K; Mabuchi S; Tomimatsu T; Yoshino K; Kimura T
    BMC Womens Health; 2022 Jun; 22(1):229. PubMed ID: 35701778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ninjin'yoeito Improves Genitourinary Symptoms in Patients With Frailty.
    Okui N; Okui MA
    Cureus; 2023 Jun; 15(6):e40767. PubMed ID: 37363115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating the usefulness of Ninjin'yoeito Kampo medicine in combination with rehabilitation therapy in patients with frailty complicated by intractable dizziness.
    Arai M
    Neuropeptides; 2021 Dec; 90():102189. PubMed ID: 34481223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of ninjin'yoeito, a Kampo (traditional Japanese) medicine, on cognitive impairment and depression in patients with Alzheimer's disease: 2 years of observation.
    Kudoh C; Arita R; Honda M; Kishi T; Komatsu Y; Asou H; Mimura M
    Psychogeriatrics; 2016 Mar; 16(2):85-92. PubMed ID: 25918972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of Ninjin'yoeito in treating severe coronavirus disease 2019 in patients in an intensive care unit.
    Aomatsu N; Shigemitsu K; Nakagawa H; Morooka T; Ishikawa J; Yamashita T; Tsuruoka A; Fuke A; Motoyama K; Kitagawa D; Ikeda K; Maeda K; Shirano M; Rinka H
    Neuropeptides; 2021 Dec; 90():102201. PubMed ID: 34753072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ninjin'yoeito Ameliorates Skeletal Muscle Complications in COPD Model Mice by Upregulating Peroxisome Proliferator-Activated Receptor γ Coactivator-1α Expression.
    Miyamoto A; Asai K; Kadotani H; Maruyama N; Kubo H; Okamoto A; Sato K; Yamada K; Ijiri N; Watanabe T; Kawaguchi T
    Int J Chron Obstruct Pulmon Dis; 2020; 15():3063-3077. PubMed ID: 33273811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between the severity of pre-frailty and the degree of adaptation of Ninjin'yoeito (NYT) on pre-frailty.
    Amitani H; Suzuki H; Kobayashi H; Murayama M; Uto NS; Kuroda E; Kobayashi Y; Kawabe M; Amitani M; Inui A; Marunaka Y
    Front Aging; 2024; 5():1304217. PubMed ID: 38681234
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Shimoyama T; Kaneda M; Yoshida S; Michihara S; Fujita N; Han LK; Takahashi R
    Front Pharmacol; 2022; 13():970697. PubMed ID: 36299904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case Report: Ninjin'yoeito May Improve Quality of Life After Hospitalization for Acute Illness in Patients With Frailty.
    Kashima M
    Front Nutr; 2021; 8():547512. PubMed ID: 33937301
    [No Abstract]   [Full Text] [Related]  

  • 14. Prophylactic efficacy of ninjin'yoeito for oxaliplatin-induced cumulative peripheral neuropathy in patients with colorectal cancer receiving postoperative adjuvant chemotherapy: a randomized, open-label, phase 2 trial (HOPE-2).
    Motoo Y; Tomita Y; Fujita H
    Int J Clin Oncol; 2020 Jun; 25(6):1123-1129. PubMed ID: 32232692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frailty Improvement by Multicomponent Drug, Ninjin'Yoeito, in Mild Cognitive Impairment and Mild Alzheimer's Disease Patients: An Open-Label Exploratory Study (FRAMINGO).
    Okahara K; Ohsawa M; Haruta-Tsukamoto A; Miyoshi R; Funahashi H; Fukutani Y; Makita S; Matsuo H; Ishida Y
    J Alzheimers Dis Rep; 2023; 7(1):107-117. PubMed ID: 36891253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and Effectiveness of Ninjin'yoeito: A Utilization Study in Elderly Patients.
    Suzuki S; Aihara F; Shibahara M; Sakai K
    Front Nutr; 2019; 6():14. PubMed ID: 30873411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Frailty on Hippocampal Volume in Patients with Chronic Obstructive Pulmonary Disease.
    Takahashi S; Hirano T; Yasuda K; Donishi T; Suga K; Doi K; Oishi K; Ohata S; Murata Y; Yamaji Y; Asami-Noyama M; Edakuni N; Matsunaga K
    Biomedicines; 2021 Aug; 9(9):. PubMed ID: 34572291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Ninjin'yoeito on frailty and short life in klotho-hypomorphic (kl/kl) mice.
    Amitani H; Chiba S; Amitani M; Michihara S; Takemoto R; Han L; Fujita N; Takahashi R; Inui A
    Front Pharmacol; 2022; 13():973897. PubMed ID: 36353482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic study of Ninjin'yoeito: Absorption and brain distribution of Ninjin'yoeito ingredients in mice.
    Matsumoto T; Takiyama M; Sakamoto T; Kaifuchi N; Watanabe J; Takahashi Y; Setou M
    J Ethnopharmacol; 2021 Oct; 279():114332. PubMed ID: 34129897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of the Hospital Anxiety and Depression Scale (HADS) in patients with chronic obstructive pulmonary disease: a pilot study.
    Dowson C; Laing R; Barraclough R; Town I; Mulder R; Norris K; Drennan C
    N Z Med J; 2001 Oct; 114(1141):447-9. PubMed ID: 11700772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.